MO-PHI-03.02: TB Treatment and Care

Target Audience

• Medical Officer-PHI

• Drug-Sensitive Tuberculosis [DS-TB]

  H5Content

• TB Treatment – Steps

  H5Content

• Treatment Regimen for DSTB – Adult

  H5Content

• Treatment Regimen for DSTB - Pediatrics

  H5Content

• Pre-treatment Counselling

  H5Content

• Pre treatment evaluation of DRTB cases

  H5Content

• Follow-up of TB patient

  H5Content

• Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen

  H5Content

• Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation

  H5Content

• Follow up sputum examination for DR-TB

  H5Content

• Interim Treatment Outcomes of DR-TB Cases

  H5Content

• Adverse Drug Reactions [ADRs]

  H5Content

• ADRs to First Line Treatment

  H5Content

• Adverse Drug Events: H Mono/Poly DR-TB Regimen

  H5Content

• TB Treatment Outcome

  H5Content

• Closing Cases and Assigning Treatment Outcomes

  H5Content

• Manage TB India Application

  H5Content